Yttriga ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

yttriga

eckert ziegler radiopharma gmbh - yttrium (90y) chloride - radionuklide bildebehandling - diagnostiske radiopharmaceuticals - brukes kun til radioaktivt merking av bærermolekyler, som er spesielt utviklet og godkjent for radioaktivt merking med dette radionuklidet. radiopharmaceutical forløper - ikke ment for bruk direkte i pasienter.

Spersallerg 0.5 mg/ ml / 0.4 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

spersallerg 0.5 mg/ ml / 0.4 mg/ ml

laboratoires théa s.a.s - antazolinhydroklorid / tetryzolinhydroklorid - Øyedråper, oppløsning uten konserveringsmiddel - 0.5 mg/ ml / 0.4 mg/ ml

Spersallerg 0.5 mg/ ml / 0.4 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

spersallerg 0.5 mg/ ml / 0.4 mg/ ml

laboratoires théa s.a.s - antazolinhydroklorid / tetryzolinhydroklorid - Øyedråper, oppløsning med konserveringsmiddel - 0.5 mg/ ml / 0.4 mg/ ml

Rybrevant ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

rybrevant

janssen-cilag international n.v.    - amivantamab - karsinom, ikke-småcellet lunge - antineoplastiske midler - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.